Company overview
Refeyn develops mass photometry instruments for rapid, label-free characterization of single biomolecules like proteins and viral vectors in solution. Key products include the compact MyMass mass photometer for sample purity and homogeneity assessment before cryo-EM or native MS, and the TwoMP system with advanced features like the MassFluidix HC upgrade for high-concentration analysis. Their technology supports biotherapeutics R&D, structural biology, and biomolecular interaction studies with automated workflows and service support.
Refeyn is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include mass photometry, refeyn, biomolecule characterization, sample purity analysis, viral vector mass.
Structured facts
- Website
- https://refeyn.com
- Markets served
- United States & Americas
- Keywords
- mass photometry, refeyn, biomolecule characterization, sample purity analysis, viral vector mass
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What mass photometry instruments does Refeyn offer for pharma R&D?
- Refeyn offers MyMass, a compact all-in-one mass photometer for quick sample purity, homogeneity, and oligomerization checks; TwoMP for advanced single biomolecule mass measurements; and MassFluidix HC for high-concentration sample analysis with rapid dilution.
- What applications are supported by Refeyn's mass photometry technology?
- Applications include sample characterization, protein interactions, oligomerization, viral vector analysis, and quality checks before cryo-EM, native MS, BLI, or SPR workflows.
- Does Refeyn provide services and support for their instruments?
- Yes, Refeyn offers service contracts, field service engineers, and personalized support to maintain instrument performance, along with software for automated mass photometry workflows.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
